Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Small

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
FEBS Letters|November 14, 1997
Expression and analysis of heparin-binding regions of the amyloid precursor protein of Alzheimer's diseaseS S Mok, G Sberna, D Heffernan, et al.
Biochemistry|November 5, 1991
A protease activity associated with acetylcholinesterase releases the membrane-bound form of the amyloid protein precursor of Alzheimer's diseaseD H Small, R D Moir, S J Fuller, et al.
Blood Neoplasia|June 24, 2025
Targeting SLFN11-regulated pathways restores chemotherapy sensitivity in AMLSara H Small, Ricardo E Perez, Elspeth M Beauchamp, et al.
Brain : a Journal of Neurology|November 15, 2007
The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanismSteven Petratos, Qiao-Xin Li, Amee J George, et al.
The Journal of Biological Chemistry|March 28, 1998
Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domainR D Moir, T Lynch, A I Bush, et al.
Journal of Neurochemistry|February 9, 2007
The beta-amyloid protein of Alzheimer's disease binds to membrane lipids but does not bind to the alpha7 nicotinic acetylcholine receptorDavid H Small, Danuta Maksel, Megan L Kerr, et al.
Annals of Neurology|July 1, 1992
An abnormality of plasma amyloid protein precursor in Alzheimer's diseaseA I Bush, S Whyte, L D Thomas, et al.
Clinical Pharmacology in Drug Development|January 21, 2026
A Human Mass Balance and Metabolism Study of [<sup>14</sup>C]-Ubrogepant in Healthy Male AdultsRamesh R Boinpally, Joshua Rowe, Pushpa Chandrasekar, et al.
Science Signaling|December 21, 2021
Induction of <i>IL19</i> expression through JNK and cGAS-STING modulates DNA damage-induced cytokine productionSara H Small, E Jessica Tang, Ryan L Ragland, et al.
Scientific Reports|March 3, 2016
N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting Enzyme-1 and NeprilysinA Ian Smith, Niwanthi W Rajapakse, Oded Kleifeld, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
FEBS Letters|November 14, 1997
Expression and analysis of heparin-binding regions of the amyloid precursor protein of Alzheimer's diseaseS S Mok, G Sberna, D Heffernan, et al.
Biochemistry|November 5, 1991
A protease activity associated with acetylcholinesterase releases the membrane-bound form of the amyloid protein precursor of Alzheimer's diseaseD H Small, R D Moir, S J Fuller, et al.
Blood Neoplasia|June 24, 2025
Targeting SLFN11-regulated pathways restores chemotherapy sensitivity in AMLSara H Small, Ricardo E Perez, Elspeth M Beauchamp, et al.
Brain : a Journal of Neurology|November 15, 2007
The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanismSteven Petratos, Qiao-Xin Li, Amee J George, et al.
The Journal of Biological Chemistry|March 28, 1998
Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domainR D Moir, T Lynch, A I Bush, et al.
Journal of Neurochemistry|February 9, 2007
The beta-amyloid protein of Alzheimer's disease binds to membrane lipids but does not bind to the alpha7 nicotinic acetylcholine receptorDavid H Small, Danuta Maksel, Megan L Kerr, et al.
Annals of Neurology|July 1, 1992
An abnormality of plasma amyloid protein precursor in Alzheimer's diseaseA I Bush, S Whyte, L D Thomas, et al.
Clinical Pharmacology in Drug Development|January 21, 2026
A Human Mass Balance and Metabolism Study of [<sup>14</sup>C]-Ubrogepant in Healthy Male AdultsRamesh R Boinpally, Joshua Rowe, Pushpa Chandrasekar, et al.
Science Signaling|December 21, 2021
Induction of <i>IL19</i> expression through JNK and cGAS-STING modulates DNA damage-induced cytokine productionSara H Small, E Jessica Tang, Ryan L Ragland, et al.
Scientific Reports|March 3, 2016
N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting Enzyme-1 and NeprilysinA Ian Smith, Niwanthi W Rajapakse, Oded Kleifeld, et al.
Pageof 27